P

Inventor

COOK PHILLIP D

US32 patents
⚠️ This page may combine multiple inventors who share the name “COOK PHILLIP D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ISIS PHARMACEUTICALS INC

23 patents
US5623065AApr 22, 1997

Gapped 2' modified oligonucleotides

ISIS PHARMACEUTICALS INC662 citations99
US5607923AMar 4, 1997

Oligonucleotides for modulating cytomegalovirus having phosphorothioate linkages of high chiral purity

ISIS PHARMACEUTICALS INC136 citations99
US5599797AFeb 4, 1997

Oligonucleotides having phosphorothioate linkages of high chiral purity

ISIS PHARMACEUTICALS INC248 citations99
US5587361ADec 24, 1996

Oligonucleotides having phosphorothioate linkages of high chiral purity

ISIS PHARMACEUTICALS INC1,412 citations99
US5587469ADec 24, 1996

Oligonucleotides containing N-2 substituted purines

ISIS PHARMACEUTICALS INC1,440 citations99
US5578718ANov 26, 1996

Thiol-derivatized nucleosides

ISIS PHARMACEUTICALS INC1,007 citations99
US5576302ANov 19, 1996

Oligonucleotides for modulating hepatitis C virus having phosphorothioate linkages of high chiral purity

ISIS PHARMACEUTICALS INC255 citations99
US5521302AMay 28, 1996

Process for preparing oligonucleotides having chiral phosphorus linkages

ISIS PHARMACEUTICALS INC243 citations99
US5359044AOct 25, 1994

Cyclobutyl oligonucleotide surrogates

ISIS PHARMACEUTICALS INC1,216 citations99
US5212295AMay 18, 1993

Monomers for preparation of oligonucleotides having chiral phosphorus linkages

ISIS PHARMACEUTICALS INC389 citations99
US5637684AJun 10, 1997

Phosphoramidate and phosphorothioamidate oligomeric compounds

ISIS PHARMACEUTICALS INC561 citations98
US5614621AMar 25, 1997

Process for preparing oligonucleotides using silyl-containing diamino phosphorous reagents

ISIS PHARMACEUTICALS INC116 citations98
US5587471ADec 24, 1996

Method of making oligonucleotide libraries

ISIS PHARMACEUTICALS INC108 citations98
US5539083AJul 23, 1996

Peptide nucleic acid combinatorial libraries and improved methods of synthesis

ISIS PHARMACEUTICALS INC782 citations98
US5506212AApr 9, 1996

Oligonucleotides with substantially chirally pure phosphorothioate linkages

ISIS PHARMACEUTICALS INC125 citations98
US5514786AMay 7, 1996

Compositions for inhibiting RNA activity

ISIS PHARMACEUTICALS INC108 citations97
US5635488AJun 3, 1997

Compounds having phosphorodithioate linkages of high chiral purity

ISIS PHARMACEUTICALS INC92 citations96
US5620963AApr 15, 1997

Oligonucleotides for modulating protein kinase C having phosphorothioate linkages of high chiral purity

ISIS PHARMACEUTICALS INC80 citations96
US5543507AAug 6, 1996

Covalently cross-linked oligonucleotides

ISIS PHARMACEUTICALS INC92 citations96
US5359051AOct 25, 1994

Compounds useful in the synthesis of nucleic acids capable of cleaning RNA

ISIS PHARMACEUTICALS INC59 citations95
US5632898AMay 27, 1997

Method for removing unreacted electrophiles from a reaction mixture

ISIS PHARMACEUTICALS INC22 citations92
US5459243AOct 17, 1995

Apparatus and processes for the large scale generation and transfer of diazomethane

ISIS PHARMACEUTICALS INC34 citations92
US6448373B1Sep 10, 2002

Phosphate linked oligomers formed of monomeric diols and processes for preparing same

ISIS PHARMACEUTICALS INC6 citations59

WARNER LAMBERT CO

6 patents

BIOTA SCIENT MANAGEMENT

2 patents

BIOTA INC

1 patent